Siva Therapeutics Inc and NanoRods LLC Partner for Uses of Gold Nanorod Technology and Cancer Therapy

BOULDER, COLORADO, June 28, 2011Siva Therapeutics announced today signing of a broad license agreement with NanoRods LLC for the use of gold nanorods in cancer therapy. As part of the agreement, Siva will gain an exclusive license, for applications in cancer therapy, to NanoRods’ strong and growing patent portfolio.NanoRods has developed unique technologies and intellectual property for the practical manufacture, purification and surface modification of gold nanorods.

“This license agreement and close collaboration with NanoRods will give Siva access to the best gold nanorod technology available today,” said Len Pagliaro, PhD, CEO of Siva. “In addition, our business partnership is designed to enable Siva and NanoRods to jointly develop even better nanorod materials and production technologies than we have at present.”

The scientific foundation of NanoRods LLC is built on many of the key scientific publications in the field of nanorod and nanoparticles technology, and new R&D continues. Elements of the license agreement include equity, cash payment, and FTE support.

About Siva Therapeutics Inc Siva Therapeutics Inc is an early stage biotechnology company developing a photothermal device cancer therapy which uses heat to irreversibly damage solid tumor tissue. The heat is delivered to tumors by infrared light that is absorbed by gold nanoparticles and reemitted as heat. The size, shape, and surface chemistry of the particles target the leaky vasculature of solid tumors, and the selective thermal sensitivity of tumor tissue enables the therapy to deliver clean margins. Siva therapy is extremely safe, effective, and competitive in cost relative to surgery, chemotherapy, and radiation for cancer treatment. For more information please visit www.sivatherapeutics.com.  

Media Contact: info@sivatherapeutics.com

About NanoRods LLC 

NanoRods, LLC is a nanotechnology company, based in the state of Maryland, with a mission is of meeting the current nanotechnology demands of industry and academia, and speeding up the development of gold nanorod-based products. NanoRods produces and sells gold nanorods, and offers nanotechnologies with applications in sensing, biotechnology and energy efficient platforms. For more information please visit www.goldnrs.com.

PDF version of this article: June 28, 2011 – Siva Therapeutics and NanoRods LLC Partner for Uses of Gold Nanorod Technology and Cancer Therapy.